Tokyo, Oct. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063387) titled 'A Study on Yogurt Consumption and Salivary IgA Using Existing Samples' on Oct. 26.
Study Type:
Observational
Primary Sponsor:
Institute - Meiji Co., Ltd.
Condition:
Condition - Healthy Adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effect of yogurt consumption on antigen-binding salivary IgA using existing samples collected in a previous study.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Participants of the previous study (UMIN000056714)
Key exclusion criteria - 1. Participants who expressed their refusal to participate in this study after the public disclosure of information about its conduct.
2. Participants from whom neither saliva nor blood samples were obtained in the previous study (UMIN000056714).
Target Size - 140
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 10 Month 15 Day
Date of IRB - 2026 Year 10 Month 15 Day
Anticipated trial start date - 2026 Year 11 Month 06 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072557
Disclaimer: Curated by HT Syndication.
